F12.921
Cannabis use, unspecified with intoxication delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F12.921 pertains to a clinical condition where an individual has used cannabis and is experiencing intoxication delirium. Cannabis, also known as marijuana, is a psychoactive drug derived from the Cannabis plant. While many use it recreationally or medicinally, excessive or certain types of use can lead to acute mental health effects, including delirium. This condition is characterized by sudden changes in mental status, confusion, and altered consciousness, often requiring prompt medical attention. Recognizing the signs and understanding the causes can aid in timely intervention and management.
Causes & Symptoms
Clinical Causes: Excessive consumption of cannabis, particularly in high doses Use of potent cannabis strains containing high levels of THC Concurrent use of other substances such as alcohol or sedatives Pre-existing mental health conditions or neurological disorders Underlying health issues that may predispose an individual to delirium Ingestion of contaminated or adulterated cannabis products
Key Symptoms: Sudden confusion or disorientation Altered levels of consciousness, ranging from drowsiness to agitation Hallucinations, often visual or auditory Disorganized thoughts and speech Impaired judgment and memory difficulties Emotional disturbances such as anxiety, paranoia, or agitation Physical signs like tachycardia (rapid heartbeat), sweating, or dilated pupils Possible seizures or tremors in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily clinical, based on a patient's history of cannabis use and presenting symptoms. Healthcare providers may perform physical examinations and neurological assessments. Laboratory tests such as blood or urine analyses can detect the presence of cannabis metabolites to confirm recent use. It's essential to differentiate intoxication delirium from other causes of delirium, including infections, metabolic imbalances, or other drug intoxications. In some cases, neuroimaging or additional tests might be employed to rule out underlying conditions.
Treatment Protocols: Management of cannabis-related intoxication delirium involves supportive care aimed at ensuring the patient's safety and stabilizing vital signs. Strategies include monitoring until the effects of cannabis subside, providing a calm environment, and correcting any underlying physiological disturbances. In severe cases, hospitalization might be necessary, especially if the individual exhibits aggressive behavior, uncontrollable symptoms, or if complications arise. Medications are typically reserved for controlling agitation or psychosis, and only under medical supervision. Long-term strategies focus on education about substance use and addressing any underlying substance use disorders.
Clinical Advice & FAQs
Billing Guidance
Is F12.921 a billable ICD-10 code?
Yes, F12.921 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F12.921?
Clinical documentation must specify the nature of Cannabis use, unspecified with intoxication delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference